A detailed history of Baldwin Brothers LLC transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Baldwin Brothers LLC holds 411 shares of DGX stock, worth $56,343. This represents 0.0% of its overall portfolio holdings.

Number of Shares
411
Holding current value
$56,343
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$137.09 - $137.09 $56,343 - $56,343
411 New
411 $56,000
Q3 2018

Oct 26, 2018

BUY
$105.42 - $114.99 $42,168 - $45,996
400 New
400 $43,000
Q1 2018

Apr 16, 2018

SELL
$96.42 - $107.88 $38,085 - $42,612
-395 Closed
0 $0
Q3 2017

Oct 26, 2017

BUY
$91.96 - $108.35 $36,324 - $42,798
395
395 $37,000

Others Institutions Holding DGX

About QUEST DIAGNOSTICS INC


  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Baldwin Brothers LLC Portfolio

Follow Baldwin Brothers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baldwin Brothers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baldwin Brothers LLC with notifications on news.